An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University Hospital
FECPEC MICI
Etude Des Facteurs Explicatifs Des Coûts de la Prise En Charge Des Patients Adultes Atteints d'Une MICI Suivis au CHRU de Nancy et traités Par biothérapie
1 other identifier
observational
119
0 countries
N/A
Brief Summary
The objective of this study is to analyze the factors influencing the medical and non-medical direct costs of patients treated with biotherapy during the last twelve months (infliximab or adalimumab), including biosimilars (infliximab biosimilars: Inflectra ™ and Remsima ™) for treating Crohn's desease or ulcerative colitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2017
CompletedFirst Submitted
Initial submission to the registry
August 9, 2017
CompletedFirst Posted
Study publicly available on registry
August 14, 2017
CompletedAugust 14, 2017
July 1, 2017
2 months
August 9, 2017
August 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective health care consumption
Desease treatment cost individual level data
one year
Eligibility Criteria
Patients who received biotherapy during the last 12 months preceeding consultation for treatment of crohn's disease or ulcerative colitis.
You may qualify if:
- Patients over 18 of age the day of consultation
- Patients with crohn's disease or ulcerative colitis.
- Patients accepting to respond to the questionnary
You may not qualify if:
- Age under 18 years , the day of consultation
- Patient that not accept or unable to complete the retrospective questionnary
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Central Hospital, Nancy, Francelead
- HEVA - Lyoncollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2017
First Posted
August 14, 2017
Study Start
November 28, 2016
Primary Completion
February 7, 2017
Study Completion
February 7, 2017
Last Updated
August 14, 2017
Record last verified: 2017-07